| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 28.223 | 38.154 | 29.490 | 11.382 | 24.497 | 14.939 | 2.779 | 1.480 | 4.528 | 4.563 |
| Total Income - EUR | 28.399 | 38.161 | 29.860 | 11.383 | 24.509 | 15.001 | 2.781 | 1.483 | 5.761 | 4.564 |
| Total Expenses - EUR | 23.543 | 32.167 | 27.125 | 19.311 | 23.956 | 13.831 | 10.055 | 7.830 | 7.461 | 9.781 |
| Gross Profit/Loss - EUR | 4.856 | 5.994 | 2.735 | -7.929 | 553 | 1.169 | -7.275 | -6.347 | -1.699 | -5.217 |
| Net Profit/Loss - EUR | 3.900 | 4.813 | 1.637 | -8.043 | 325 | 922 | -7.341 | -6.383 | -1.699 | -5.217 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Expertum Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 13.612 | 9.496 | 9.927 | 9.075 | 8.340 | 7.633 | 7.225 | 7.008 | 6.747 | 6.472 |
| Current Assets | 2.559 | 7.244 | 5.097 | 1.591 | 5.538 | 6.678 | 3.082 | 2.838 | 7.628 | 3.934 |
| Inventories | 434 | 0 | 0 | 0 | 456 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 377 | 5.011 | 3.978 | 780 | 2.358 | 3.569 | 2.406 | 2.441 | 2.671 | 3.310 |
| Cash | 1.748 | 2.233 | 1.118 | 811 | 2.725 | 3.109 | 676 | 397 | 4.957 | 624 |
| Shareholders Funds | -7.418 | -2.529 | -849 | -8.876 | -8.378 | -7.297 | -14.477 | -20.904 | -22.540 | -27.456 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 24.850 | 19.831 | 16.322 | 19.801 | 22.269 | 21.621 | 24.783 | 30.763 | 36.935 | 37.862 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Expertum Pharma Srl